Mari Iida
- Oncology top 2%
- HER2/EGFR in Cancer Research 18
- Pancreatic and Hepatic Oncology Research 6
- Cancer-related Molecular Pathways 6
- Colorectal Cancer Treatments and Studies 6
- Cancer Research top 5%
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer 6
- Immunology top 5%
- Phagocytosis and Immune Regulation 11
-
- Lung Cancer Treatments and Mutations 20
-
- Monoclonal and Polyclonal Antibodies Research 6
Mari Iida
60 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 102
- Oncology 1.3k
- Cancer Research 429
- Molecular Biology 1.5k
- Immunology 456
- Pulmonary and Respiratory Medicine 620
Countries citing papers authored by Mari Iida
This map shows the geographic impact of Mari Iida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Iida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Iida more than expected).
Fields of papers citing papers by Mari Iida
This network shows the impact of papers produced by Mari Iida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Iida. The network helps show where Mari Iida may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mari Iida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 15 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 7 | |
| 5 | 2020 | 30 | |
| 6 | 2020 | 17 | |
| 7 | 2020 | 91 | |
| 8 | 2018 | 41 | |
| 9 | 2017 | 28 | |
| 10 | 2016 | 5 | |
| 11 | 2015 | 89 | |
| 12 | 2014 | 40 | |
| 13 | 2014 | 150 | |
| 14 | 2013 | 5 | |
| 15 | 2013 | 23 | |
| 16 | 2011 | 12 | |
| 17 | 2010 | 13 | |
| 18 | The Acceptance of Western Piano Music in Japan and the Career of Takahiro Sonoda | 2009 | 1 |
| 19 | 2009 | 249 | |
| 20 | 2007 | 13 |
About Mari Iida
Mari Iida is a scholar working on Oncology, Cancer Research, Immunology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 62 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (20 papers), HER2/EGFR in Cancer Research (18 papers), Phagocytosis and Immune Regulation (11 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Cancer-related Molecular Pathways (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (429 citations), Molecular Biology (1.5k citations), Immunology (456 citations) and Pulmonary and Respiratory Medicine (620 citations). Mari Iida has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Deric L. Wheeler, Toni M. Brand, Emily Dunn, Chunrong Li, Neha Luthar, Amol J. Ghia, Megan M. Starr, Ravi Salgia, Mahmoud Toulany and David A. Campbell. Their work appears in journals such as Molecular Cancer Therapeutics, Radiotherapy and Oncology, Clinical Cancer Research, Cancers and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.